Skip to main content
Clinical Trials/NL-OMON41324
NL-OMON41324
Completed
Not Applicable

Muscle properties in children with cerebral palsy undergoing orthopaedic surgical intervention to improve gait - Muscle properties in cerebral palsy after surgery to improve gait

Vrije Universiteit Medisch Centrum0 sites86 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral palsy
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
86
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Clinical diagnosis of spastic cerebral palsy
  • 2\. Indication for surgical lengthening of thigh and/or calf muscles / or injections with Botuline A\-Toxine in combination with a bony procedure targeting the increase of knee extension
  • 3\. Gross Motor Function Classification System Class I\-III (ability to walk with or without aids)
  • 4\. Age: 6\-20 years ;Patients for reliability\-study
  • 1\. Clinical diagnosis of spastic cerebral palsy
  • 2\. Gross Motor Function Classification System Class I\-III (ability to walk with or without aids)
  • 3\. Age: 8\-16 years
  • Control group (2 groups, for detailed description see protocol page 12/13\):
  • 1\. Typically developing and healthy persons
  • 2\. Age: 6\-20 years

Exclusion Criteria

  • 1\. Treatment of muscles, which are indicated for surgical procedures, with Botuline A \-Toxine within three months before surgery.
  • 2\. A pre\-surgical treatment with selective dorsal rhizotomy, intrathecal baclofen pump or prior surgery of treated muscle
  • 3\. Major disease or accident one year prior to measurements or a disturbed normal activity level of the child for more than three weeks in the last half year
  • 4\. 24\-hour casting for more than two weeks, that includes the treated muscle three month prior to surgery
  • 5\. Additional neuromuscular, orthopaedic, inflammatory or systemic diseases which can influence walking ability or muscle properties
  • 6\. Medication that influences neuromuscular properties three month prior to surgery
  • 7\. Parents/guardians or child do not cooperate well enough to take part in the project;Patients for reliability\-study \& 1st Control group:
  • Same as 1\., 3\. and 7\. for patients;2nd control group:
  • Sames as for patient

Outcomes

Primary Outcomes

Not specified

Similar Trials